As Ozempic shortages persist and prices climb above R4,000/month, compounding pharmacies across Gauteng, Cape Town, and Durban are offering semaglutide injections at a fraction of the cost. But is compounded semaglutide safe? Is it legal? And does it actually work the same as the brand-name product? Here is everything South Africans need to know.
This article is for informational purposes only. Compounded medications carry risks that differ from registered pharmaceuticals. Always consult a doctor before starting any semaglutide product, whether brand or compounded. Never buy semaglutide from unverified online sources, social media sellers, or without a prescription.
Compounded semaglutide is the same active ingredient found in Ozempic (semaglutide), but prepared by a compounding pharmacy rather than manufactured by Novo Nordisk in a certified pharmaceutical facility.
A compounding pharmacy takes pharmaceutical-grade semaglutide base powder and mixes it into an injectable solution — typically in a multi-dose vial rather than the pre-filled FlexTouch pen used for Ozempic. The patient then draws each dose using an insulin syringe.
Think of it like this: brand Ozempic is a factory-sealed, tested, and SAHPRA-registered product. Compounded semaglutide is a pharmacist-prepared version using the same active ingredient but without the factory-level quality assurance, clinical trial data, or regulatory registration.
| Factor | Brand Ozempic (Novo Nordisk) | Compounded Semaglutide |
|---|---|---|
| Active ingredient | Semaglutide (acetate) | Semaglutide (may be acetate or sodium salt) |
| SAHPRA registered | Yes — full registration | No — compounded under GPP |
| Clinical trial data | STEP & SUSTAIN trials (10,000+ patients) | None specific to compounded product |
| Delivery device | Pre-filled FlexTouch pen (dial-a-dose) | Multi-dose vial + insulin syringe |
| Dose accuracy | Factory-calibrated to ±1% | Depends on pharmacist & patient technique |
| Sterility testing | Batch-tested to ICH guidelines | Varies — ask for CoA |
| Stability data | 36 months (refrigerated), 56 days in use | Typically 28–90 days (limited data) |
| Cost per month (2026) | R3,500–R5,500 | R800–R2,500 |
| Medical aid cover | Possible with Section 21 (diabetes) | Almost never covered |
| Adverse event reporting | Pharmacovigilance system in place | No formal system |
| Supply consistency | Subject to global shortages | Generally more available |
Yes, but with important caveats. In South Africa, compounding pharmacies operate under the Pharmacy Act (Act 53 of 1974) and Good Pharmacy Practice (GPP) standards set by the South African Pharmacy Council (SAPC). A registered pharmacist may compound a medication for a specific patient based on a valid prescription from a licensed medical practitioner.
What is not legal: buying semaglutide without a prescription, importing it from overseas websites, or purchasing from unregistered sellers on social media platforms like Facebook Marketplace, Telegram groups, or WhatsApp.
This is the most important technical issue South African patients should understand. Not all semaglutide is the same at the molecular level.
Brand Ozempic uses semaglutide base (acetate buffer). Some compounding pharmacies source semaglutide sodium salt — a different salt form that may behave differently in the body. The sodium salt form:
“Which salt form of semaglutide do you use — base/acetate or sodium salt? Do you adjust the dose calculation for the salt factor?” If they cannot answer this question clearly, consider it a red flag.
Prices vary between pharmacies, but here is a representative range based on Gauteng and Western Cape compounding pharmacy pricing as of May 2026:
| Weekly Dose | Monthly Cost (Compounded) | Monthly Cost (Brand Ozempic) | You Save |
|---|---|---|---|
| 0.25mg (starting) | R600–R900 | R3,500–R4,200 | ~R3,000/month |
| 0.5mg | R800–R1,200 | R3,500–R4,200 | ~R2,700/month |
| 1.0mg | R1,200–R1,800 | R3,800–R4,800 | ~R2,600/month |
| 1.7mg | R1,500–R2,200 | R4,500–R5,200 | ~R3,000/month |
| 2.4mg (Wegovy dose) | R1,800–R2,500 | R5,000–R5,500+ | ~R3,000/month |
Annual savings potential: At the 1.0mg maintenance dose, switching from brand Ozempic to compounded semaglutide could save approximately R30,000–R36,000 per year. That is a significant amount — roughly the cost of a decent holiday or six months of medical aid contributions.
The price savings are attractive, but compounded semaglutide carries risks that brand Ozempic does not. Understanding these helps you make an informed decision.
Brand Ozempic pens deliver doses calibrated to within 1% accuracy. With compounded vials, the concentration depends on the pharmacist’s preparation, and the dose depends on your ability to draw the correct volume with a syringe. A small error in either direction can mean:
Injectable medications must be sterile. Brand Ozempic is manufactured in ISO-certified clean rooms with batch-level sterility testing. Compounding pharmacies vary widely in their sterility protocols. Multi-dose vials that are repeatedly punctured have an inherent contamination risk over their use period.
Novo Nordisk has 36 months of stability data for Ozempic in its pen device. Compounded semaglutide typically has 28–90 day stability claims, often based on limited or no proprietary testing. If the peptide degrades before you finish the vial, you may be injecting partially inactive medication.
The inactive ingredients (buffers, preservatives, tonicity agents) in compounded formulations may differ from Ozempic. These excipients can affect absorption, injection site reactions, and overall tolerability.
If you experience a serious side effect from brand Ozempic, it is reported through Novo Nordisk’s pharmacovigilance system and SAHPRA’s adverse event database. Compounded products have no such system. Problems may go unreported and untracked.
In the United States, the FDA has documented multiple hospitalisations linked to compounded semaglutide, including cases of severe hypoglycaemia, contamination, and incorrect dosing. While SA’s compounding landscape is different, the underlying risks are the same. In December 2024, the FDA issued a formal warning against compounded semaglutide and tirzepatide products.
If you decide that compounded semaglutide is right for you (after consulting your doctor), use this checklist to evaluate the pharmacy:
In 2025, SAHPRA issued multiple warnings about counterfeit GLP-1 products entering South Africa. Some tested samples contained no semaglutide at all, while others contained dangerous contaminants including heavy metals and bacterial endotoxins.
Whether you use brand or compounded semaglutide, the dietary fundamentals are identical. Semaglutide reduces appetite, but you still need to eat well to maintain muscle mass, get adequate nutrition, and support long-term results.
Aim for 1.2–1.6g protein per kg of body weight daily to prevent the muscle loss that commonly accompanies rapid weight loss on semaglutide. A 80kg person needs 96–128g protein per day. Track it for the first month until it becomes habit.
SAHPRA’s position on compounded semaglutide is evolving. As of mid-2026:
Monitor SAHPRA’s media releases at sahpra.org.za for updates. If regulations tighten, patients currently using compounded semaglutide may need to transition to brand Ozempic or explore alternative weight loss medications.
Yes, when prepared by a SAPC-registered compounding pharmacy with a valid prescription from a licensed doctor. It is not SAHPRA-registered but operates under Good Pharmacy Practice (GPP) rules. Buying without a prescription or from unregistered sources is illegal.
Typically 50–70% cheaper. Brand Ozempic costs R3,500–R5,500/month while compounded versions range from R800–R2,500/month depending on dose and pharmacy. Annual savings can reach R30,000–R36,000 at maintenance doses.
If the active ingredient is correctly sourced and compounded, it should be pharmacologically identical. However, there is no clinical trial data for any specific compounded product. Differences in purity, salt form, concentration accuracy, and stability can all affect real-world outcomes.
Almost certainly not. South African medical aids (Discovery, Bonitas, Momentum, etc.) only cover SAHPRA-registered medications with NAPPI codes. Compounded semaglutide has no NAPPI code. You will pay entirely out of pocket.
Your compounding pharmacy should provide injection training. Generally: wash hands, clean the vial top with an alcohol swab, draw air into the syringe equal to your dose volume, insert needle into vial, inject air, invert vial and draw your dose, tap out air bubbles, inject subcutaneously into abdomen or thigh. Rotate injection sites. If you are not confident, ask your pharmacy for a demonstration or see our injection guide.
Key questions: (1) Which salt form of semaglutide do you use? (2) Can I see the Certificate of Analysis for the raw ingredient? (3) What sterility testing do you perform on injectables? (4) What is the beyond-use date and how was it determined? (5) How should I store this product? (6) Are you SAPC-registered with a current GPP certificate?
Not sure whether compounded semaglutide, brand Ozempic, Mounjaro, Saxenda, or another option is right for you? Our comprehensive comparison covers all 7 medications available in SA.
View Full ComparisonCompounded semaglutide is a legitimate option for South Africans who cannot afford brand Ozempic or face supply shortages. The cost savings are real — potentially R30,000+ per year. But those savings come with trade-offs in quality assurance, regulatory oversight, and clinical evidence.
If you go the compounded route:
If budget is your primary concern, also explore other weight loss medication alternatives that may be more affordable, including Contrave (from ~R1,200/month) or supervised intermittent fasting programs that require no medication at all.